(Q27285487)

GS-9620 (English)

14 October 2016

C₂₂H₃₀N₆O₂

1 reference

GS-9620 (English)

14 October 2016

CCCCOC1=NC2=C(C(=N1)N)NC(=O)CN2CC3=CC(=CC=C3)CN4CCCC4

1 reference

CAS COVID-19 Anti-Viral Candidate Compounds

GS-9620 (English)

14 October 2016

0 references

Identifiers

InChI

InChI=1S/C22H30N6O2/c1-2-3-11-30-22-25-20(23)19-21(26-22)28(15-18(29)24-19)14-17-8-6-7-16(12-17)13-27-9-4-5-10-27/h6-8,12H,2-5,9-11,13-15H2,1H3,(H,24,29)(H2,23,25,26)

1 reference

GS-9620 (English)

14 October 2016

1 reference

Global Substance Registration System

GS-9620 (English)

14 October 2016

1 reference

UNII

O8M467C50G

vesatolimod (English)

14 October 2016

1 reference

vesatolimod (English)

14 October 2016

2 references

GS-9620 (English)

retrieved

14 October 2016

1 reference

CHEMBL2424780 (English)

14 October 2016

2 references

inferred from InChIKey

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

1 reference

2 references

DSSTOX compound identifier

DTXCID7076232

0 references

DrugBank ID

DB12687

1 reference

Human Metabolome Database ID

HMDB0252944

2 references

based on heuristic

inferred from InChIKey

Global Substance Registration System

UNII

O8M467C50G

2 references

stated in

UNII

O8M467C50G

vesatolimod (English)

retrieved

14 October 2016